Sangamo granted authorisation of first-in-human CAR-Treg trial

3rd December 2019 Uncategorised 0

The company is set to conduct the first-in-human clinical trial of the novel cell therapy, TX200.

More: Sangamo granted authorisation of first-in-human CAR-Treg trial
Source: News